February 10, 2016 | Israeli medical device company Via Surgical has raised $6 million for its cartridge-based hernia repair device FasTouch, which has already received FDA approval. The device includes a reloadable cartridge with lockable sutures that close around the mesh and the tissue, which helps prevent foreign objects from entering. Benslie Investment Group led the funding and Nicolas Weinstein, a managing partner at Benslie, will join the company’s board of directors. “Their investment will greatly support the increasing clinical demand for improved fixation through our development and commercialization efforts in 2016,” Via Surgical CEO Lena Levin said in a statement.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Tel Aviv University Ranked 7th In World For Global Entrepreneurship
October 01, 2024
IIA Backs R&D By Startup Using Bacteria To Help Crops Grow
September 30, 2024
GreenTech Startup Receives €5M European Sustainability Grant
September 30, 2024
Facebook comments